For Vaccines
For Vaccines
SeromYx helps clients develop better vaccines in all stages of discovery and development. Systems Serology was originally developed to support vaccine discovery and development and has been used in over 50 projects from understanding correlates of protection to providing surrogate endpoint data for regulatory submission.
1. DISCOVERY
What function or mix of function correlates with protection?
Case Study: Preclinical vaccine-mediated protection via Antibody Dependent Cellular Phagocytosis (ADCP)
2. LEAD SELECTION
What product construct best delivers the desired mix of function?
Case Study: Immune correlate–guided vaccine development and application of Antibody Dependent Cellular Phagocytosis (ADCP) in parallel trial testing
3. ASSAY DEVELOPMENT, QUALIFICATION, VALIDATION
Which assays need to be demonstrated to be statistically robust so that data from them can be included in regulatory filings?
Case Study: Qualifying an assay to support SARS-CoV2 vaccine clinical trails.
4. CLINICAL TESTING
Tracking specified functions in clinical trial samples as a surrogate clinical endpoint.
Case Study: Coming soon
5. MANUFACTURING SCALE-UP
SeromYx is fully GCLP-accredited, and assays are conducted under GCLP defined standards
Case Study: Coming soon
Let's Talk - Contact us today to discuss your project.